Thomas Reilly
Director of Finance/CFO chez AMARIN CORPORATION PLC
Fortune : 191 890 $ au 31/03/2024
Provenance du réseau au premier degré de Thomas Reilly
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 32 | |
| Public Company | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Thomas Reilly via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer Chief Executive Officer | |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chief Operating Officer Human Resources Officer | |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HURON CONSULTING GROUP INC. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member | |
| VALERITAS HOLDINGS, INC. | Medical Specialties | Chief Executive Officer | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| State University of New York at Albany | College/University | Undergraduate Degree | |
| ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Yale New Haven Health Services Corp.
 Yale New Haven Health Services Corp. Miscellaneous Commercial ServicesCommercial Services Yale-New Haven Health Services Corp. operates as a non-profit organization that provides healthcare services. It offers geriatrics, oncology, neurology and neurosurgery, orthopedics, primary care, transplantation, clinical programs and services, health education, and research and clinical trials. The company was founded in 1995 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | President | |
| The University of Texas Southwestern Medical Center | College/University | Doctorate Degree | |
Taro Pharmaceuticals U.S.A., Inc.
 Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a private company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY. | Pharmaceuticals: Generic | Director of Finance/CFO | |
| Greater Philadelphia Life Sciences Congress | Director/Board Member | ||
Prothena Biosciences, Inc.
 Prothena Biosciences, Inc. BiotechnologyHealth Technology Part of Prothena Corp. Plc, Prothena Biosciences, Inc. is a private company that specializes in the biology of misfolded proteins. The company is based in South San Francisco, CA. The company has over 3 decades of expertise in this field and offer a range of services including science, pipeline, clinical trial information, and more. | Biotechnology | Chairman | |
| Harvard Business School | College/University | Masters Business Admin Graduate Degree | |
| Harvard Law School | College/University | Graduate Degree | |
| Georgetown University Law Center | College/University | Graduate Degree Graduate Degree | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Chairman | |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| INFLARX N.V. | Biotechnology | General Counsel Corporate Officer/Principal | |
| University of Illinois At Urbana–Champaign | College/University | Masters Business Admin | |
| ARMATA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| SARISSA CAPITAL ACQUISITION CORP. | Financial Conglomerates | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 42 |
| Canada | 4 |
| Royaume-Uni | 3 |
| Israël | 2 |
| Australie | 2 |
Sectorielle
| Health Technology | 33 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 6 |
Opérationnelle
| Director/Board Member | 154 |
| Independent Dir/Board Member | 65 |
| Corporate Officer/Principal | 63 |
| Chairman | 36 |
| Undergraduate Degree | 24 |
Relations les plus connectées
| Insiders | |
|---|---|
| Joseph Zakrzewski | 30 |
| David Stack | 27 |
| Per Wold-Olsen | 24 |
| Lars Ekman | 21 |
| Erin Enright | 19 |
| Keith Horn | 19 |
| Kristine Peterson | 18 |
| Alfonso Zulueta | 16 |
| Jan van Heek | 15 |
| Jason Marks | 11 |
| David Keenan | 11 |
| Odysseas Kostas | 11 |
| Patrick O’Sullivan | 11 |
| Aaron Berg | 9 |
| Murray Stewart | 9 |
- Bourse
- Insiders
- Thomas Reilly
- Connexions Sociétés
